Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, creating synergistic effects that enhance insulin secretion, suppress appetite, slow gastric emptying, and increase energy expenditure
Protein supports muscle maintenance, appetite control, and blood sugar stability
Recent research published in journals like JAMA Psychiatry and Scientific Reports suggests that this "quieting" effect extends beyond food
For some people, nausea is mild and goes away over time
It is prescribed to patients with chronic obesity or overweight individuals living with a weight-associated health condition
Neither medication is currently available in Canada through traditional channels, though Mazdutide has already received regulatory approval in China and sits closer to global market availability
US$ 22.04
US$ 23.40
US$ 28.47
